2007~2014년 건강보험심사평가 등을 통해 HBV 항바이러스제를 새로 처방받은 196,541명의 환자를 확인하였다.
We identified 196,541 patients who were newly prescribed antiviral treatment for HBV using Korean Health Insurance Review and Assessment during 2007-2014.